Investors and Media

Sangamo is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered DNA-binding proteins as novel therapeutics to treat unmet medical needs. We are worldwide leaders in developing zinc finger DNA-binding proteins (ZFPs) for therapeutic gene regulation and modification. Our ZFP technology platform has multiple applications in:

• Human Therapeutics
• High-value Research Tools
• Transgenic Animals
• Cell-line Engineering for Protein Manufacturing
• Plant Agriculture